Search research articles
Contact Us
Filters
Showing results (1521-1530 of 1,553) with videos related to
Page
of 156
Sort By:
Advances in Therapy
|
September 9, 2020
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial
Jin Li, Weijian Guo, Yuxian Bai, et al.
Cancer Communications (London, England)
|
October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei, et al.
Oncotargets and Therapy
|
August 19, 2021
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer
Shukui Qin, Rui-Hua Xu, Lin Shen, et al.
Clinical Colorectal Cancer
|
October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study
Ann-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Cell Regeneration (London, England)
|
January 14, 2025
Standard: Human gastric organoids
Fan Hong, Ronghui Tan, Ting Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2015
Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
Shu-Sheng Jiao, Xiu-Qing Yao, Yu-Hui Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
July 5, 2024
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers
Zhenghang Wang, Siyuan Cheng, Yanhong Yao, et al.
Neuroendocrinology
|
July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Eric Raymond, Matthew H Kulke, Shukui Qin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
Jian Li, Jun Zhang, Yanqiao Zhang, et al.
Cell Regeneration (London, England)
|
December 27, 2024
Standard: Human gastric cancer organoids
Ronghui Tan, Fan Hong, Ting Wang, et al.
Page
of 156
Search research articles
Search
Showing results (1521-1530 of 1,553) with videos related to
Sort By:
Page
of 156
Advances in Therapy
|
September 9, 2020
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial
Jin Li, Weijian Guo, Yuxian Bai, et al.
Cancer Communications (London, England)
|
October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei, et al.
Oncotargets and Therapy
|
August 19, 2021
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer
Shukui Qin, Rui-Hua Xu, Lin Shen, et al.
Clinical Colorectal Cancer
|
October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study
Ann-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Cell Regeneration (London, England)
|
January 14, 2025
Standard: Human gastric organoids
Fan Hong, Ronghui Tan, Ting Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2015
Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
Shu-Sheng Jiao, Xiu-Qing Yao, Yu-Hui Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
July 5, 2024
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers
Zhenghang Wang, Siyuan Cheng, Yanhong Yao, et al.
Neuroendocrinology
|
July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Eric Raymond, Matthew H Kulke, Shukui Qin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
Jian Li, Jun Zhang, Yanqiao Zhang, et al.
Cell Regeneration (London, England)
|
December 27, 2024
Standard: Human gastric cancer organoids
Ronghui Tan, Fan Hong, Ting Wang, et al.
Page
of 156